Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) saw a large increase in short interest in October. As of October 30th, there was short interest totaling 2,817 shares, an increase of 63.4% from the October 15th total of 1,724 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 95,128 shares, the short-interest ratio is presently 0.0 days.
Guided Therapeutics Stock Performance
OTCMKTS:GTHP traded down $0.01 during mid-day trading on Monday, reaching $0.11. The stock had a trading volume of 3,200 shares, compared to its average volume of 27,274. The firm has a 50 day moving average price of $0.19 and a two-hundred day moving average price of $0.25. The stock has a market capitalization of $10.80 million, a P/E ratio of -2.75 and a beta of 0.78. Guided Therapeutics has a one year low of $0.10 and a one year high of $0.54.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last issued its quarterly earnings results on Monday, November 16th. The company reported ($0.01) EPS for the quarter.
Guided Therapeutics Company Profile
Guided Therapeutics is a medical technology company focused on developing tools for the detection of cervical disease. Its principal product is the LuViva Advanced Cervical Scan, a non-invasive device designed to assess cervical tissue for signs associated with precancerous changes and cancer. LuViva uses optical technologies to examine tissue and provide information that can support cervical disease evaluation. The company’s work centers on offering an alternative to diagnostic approaches that rely on collecting and analyzing tissue samples.
Recommended Stories
- Five stocks we like better than Guided Therapeutics
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
